Refresh

Marksans Pharma Ltd. - Research Center

524404 MARKSANS Group (A) BSE data
Back to Company

Results

Statement

More

Profit & Loss Account
(Rs crore)
Mar ' 24 Mar ' 23 Mar ' 22 Mar ' 21 Mar ' 20
Income

Operating income

853.27 655.20 658.29 599.55 433.42
Expenses

Material consumed

478.94 394.45 377.59 337.91 243.03

Manufacturing expenses

26.04 14.24 11.27 10.90 8.95

Personnel expenses

77.19 56.09 60.46 54.64 48.51

Selling expenses

- - - - -

Adminstrative expenses

131.17 98.52 95.25 82.38 61.43

Expenses capitalised

- - - - -

Cost of sales

713.34 563.30 544.57 485.84 361.93

Operating profit

139.94 91.90 113.72 113.71 71.49

Other recurring income

62.07 60.48 42.25 31.16 0.17

Adjusted PBDIT

202.01 152.39 155.97 144.87 71.66

Financial expenses

0.99 3.61 3.80 5.34 7.29

Depreciation

29.13 16.74 17.66 15.19 11.64

Other write offs

- - - - -

Adjusted PBT

171.89 132.04 134.51 124.33 52.73

Tax charges

38.13 29.17 30.52 25.95 14.82

Adjusted PAT

133.76 102.87 103.99 98.38 37.90

Non recurring items

0.28 -0.59 0.05 -0.20 0.16

Other non cash adjustments

- - - - -

Reported net profit

134.04 102.28 104.03 98.19 38.07

Earnigs before appropriation

367.65 257.48 165.44 65.50 -24.67

Equity dividend

22.66 10.17 10.23 4.09 2.47

Preference dividend

- - - - -

Dividend tax

- - - - -

Retained earnings

345.00 247.31 155.21 61.41 -27.14
Sectoral Indices Market Indicators Listed Companies Gainers Losers Mutual Funds Portfolio Watchlist
© 2024 Rediff.com